ATE298342T1 - Verfahren zur herstellung von substanz gm-95 - Google Patents

Verfahren zur herstellung von substanz gm-95

Info

Publication number
ATE298342T1
ATE298342T1 AT01270537T AT01270537T ATE298342T1 AT E298342 T1 ATE298342 T1 AT E298342T1 AT 01270537 T AT01270537 T AT 01270537T AT 01270537 T AT01270537 T AT 01270537T AT E298342 T1 ATE298342 T1 AT E298342T1
Authority
AT
Austria
Prior art keywords
group
general formula
thiol
produced
forming
Prior art date
Application number
AT01270537T
Other languages
English (en)
Inventor
Shozo Yamada
Kazuhiko Shigeno
Kazuhiro Kitagawa
Shigeo Okajima
Tetsuji Asao
Original Assignee
Sosei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei Co Ltd filed Critical Sosei Co Ltd
Application granted granted Critical
Publication of ATE298342T1 publication Critical patent/ATE298342T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01270537T 2000-12-12 2001-12-12 Verfahren zur herstellung von substanz gm-95 ATE298342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000377167 2000-12-12
PCT/JP2001/010870 WO2002048153A1 (en) 2000-12-12 2001-12-12 Process for preparing substance gm-95

Publications (1)

Publication Number Publication Date
ATE298342T1 true ATE298342T1 (de) 2005-07-15

Family

ID=18845932

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270537T ATE298342T1 (de) 2000-12-12 2001-12-12 Verfahren zur herstellung von substanz gm-95

Country Status (12)

Country Link
US (1) US6818764B2 (de)
EP (1) EP1350794B1 (de)
JP (1) JP4006589B2 (de)
KR (1) KR100537595B1 (de)
CN (1) CN1253458C (de)
AT (1) ATE298342T1 (de)
AU (2) AU2002222604B2 (de)
CA (1) CA2436942C (de)
DE (1) DE60111651T2 (de)
ES (1) ES2240336T3 (de)
PT (1) PT1350794E (de)
WO (1) WO2002048153A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2517850A1 (en) * 2003-03-04 2004-09-16 Sosei Co., Ltd. Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
JP4876220B2 (ja) * 2005-05-13 2012-02-15 国立大学法人東京農工大学 テロメスタチン誘導体
US8093235B2 (en) 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
US8729060B2 (en) 2007-08-02 2014-05-20 Rutgers, The State University Of New Jersey Macrocyclic polyoxazole compounds and use thereof
WO2009018551A2 (en) * 2007-08-02 2009-02-05 Rutgers, The State University Of New Jersey Therapeutic compounds
WO2011057126A1 (en) 2009-11-05 2011-05-12 Rutgers, The State University Of New Jersey Therapeutic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100446323B1 (ko) 1998-10-23 2004-08-30 다이호야쿠힌고교 가부시키가이샤 Ｇｍ-95 물질, 이의 제조 방법 및 용도

Also Published As

Publication number Publication date
EP1350794A4 (de) 2004-12-22
CN1479742A (zh) 2004-03-03
PT1350794E (pt) 2005-09-30
CN1253458C (zh) 2006-04-26
HK1061686A1 (zh) 2004-09-30
KR100537595B1 (ko) 2005-12-19
US20040049029A1 (en) 2004-03-11
WO2002048153A1 (en) 2002-06-20
EP1350794B1 (de) 2005-06-22
DE60111651D1 (de) 2005-07-28
ES2240336T3 (es) 2005-10-16
AU2260402A (en) 2002-06-24
AU2002222604B2 (en) 2006-06-08
CA2436942C (en) 2008-07-22
US6818764B2 (en) 2004-11-16
JP4006589B2 (ja) 2007-11-14
CA2436942A1 (en) 2002-06-20
DE60111651T2 (de) 2006-05-18
JPWO2002048153A1 (ja) 2004-04-15
EP1350794A1 (de) 2003-10-08
KR20040014437A (ko) 2004-02-14

Similar Documents

Publication Publication Date Title
HUP0102843A2 (hu) Eljárás (3-izoxazolinil)-acil-benzolok előállítására
EP1277752A4 (de) Verfahren zur herstellung von optisch-aktiven sulfoxid-derivaten
DE69534029D1 (de) Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung
ATE154016T1 (de) Verfahren zur herstellung von chlorothiazolderivaten
DE69621297D1 (de) Verfahren zur Herstellung wasserlöslicher organischer Silizium-Verbindungen
ATE337805T1 (de) Medizinische materialien und verfahren zu deren herstellung
EP1350794A4 (de) Verfahren zur herstellung von substanz gm-95
DE60125378D1 (de) Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen
BR0112373A (pt) Compostos de benzoxazol, processo para a produção dos mesmos e herbicidas
ATE277915T1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
ATE350372T1 (de) Verfahren und oxazolidin zwischenprodukt zur herstellung von taxanen
DE60105314D1 (de) Verfahren zur herstellung von taxanderivaten
EP1216988A4 (de) Thioalkylamin-derivate und verfahren zu ihrer herstellung
ATE288891T1 (de) Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen
ATE246688T1 (de) Verfahren zur herstellung von opiaten
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
DE50209620D1 (de) Verfahren zur Herstellung von kristallinem Cholinascorbat
ATE315568T1 (de) Verfahren zur herstellung antibakterieller verbindungen vom carbapenem-typ
ATE480512T1 (de) Verfahren zur herstellung einer epoxytriazolverbindung und zwischenprodukt dafür
DE69714875D1 (de) Verfahren zur Herstellung von hetero-bizyklischem Alkohol-Enantiomer
ATE265421T1 (de) Verfahren zur herstellung von midodrin
ATE311375T1 (de) Verfahren zur herstellung antiosteoporicagenz
ATE350362T1 (de) Verfahren zur herstellung von bicyclischen verbindungen und deren zwischenstufen
DE69940423D1 (de) Verfahren zur herstellung von butantriol-derivaten
ATE142195T1 (de) Verfahren zur herstellung von fluorbenzolderivaten und verwandter verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1350794

Country of ref document: EP

REN Ceased due to non-payment of the annual fee